Liraglutide Acetate
Liraglutide Acetate – GLP-1 analogue peptide API for metabolic and diabetes research.
Liraglutide Acetate (CAS 204656-20-2) is a GLP-1 analogue peptide used in metabolic and diabetes research. COA and MSDS are available to support pharmaceutical development and regulated sourcing workflows.
Technical Overview
Liraglutide Acetate – CAS 204656-20-2
Liraglutide Acetate – GLP-1 analogue peptide API for metabolic and diabetes research.
CAS Number
204656-20-2
Therapeutic Area
Metabolic, Diabetes Research
Description
Liraglutide Acetate (CAS 204656-20-2) is a GLP-1 analogue peptide used in metabolic and diabetes research. COA and MSDS are available to support pharmaceutical development and regulated sourcing workflows.
Amino Acid Sequence
GLP-1 Analogue
Keywords
Quick Information
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.